Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 42

Trial Status

Completed2
Other1

Role Distribution

Principal Investigator2
Other Roles1
PI Rate67%

Activity Timeline

Clinical Trials (3)

NCT03024307Not ApplicableCompleted
The Effect of OPCSP on Adherence and Clinical Outcomes Among Patients With Rheumatic Diseases
Rheumatic Diseases
StudychairStart date: 2017-01-18
NCT02741960Phase 4Completed
The Effect of Metformin on Reducing Lupus Flares
Systemic Lupus Erythematosus
PrincipalinvestigatorStart date: 2016-05-24
NCT02821689Phase 4Unknown
Pirfenidone in Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis
DermatopolymyositisInterstitial Lung Disease
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Leighton Chan, M.D.

National Institutes of Health Clinical Center (CC)

Related
9 trials

Shared therapeutic areas:

Lung Diseases, InterstitialRheumatic DiseasesLupus Erythematosus, Systemic
Similarity Score23%

He Huang, PhD

First Affiliated Hospital of Zhejiang University

Related
11 trials

Shared therapeutic areas:

DermatomyositisLupus Erythematosus, Systemic
Similarity Score15%

Sarfaraz A Hasni, M.D.

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Related
10 trials

Shared therapeutic areas:

Lupus Erythematosus, SystemicRheumatic Diseases
Similarity Score15%

Konrad E Bloch, MD

University Hospital, ZĂ¼rich

Related
19 trials

Shared therapeutic areas:

Lung Diseases, Interstitial
Similarity Score8%

Xianyun Wang, Doctor

The First Hospital of Hebei Medical University

Related
4 trials

Shared therapeutic areas:

Lupus Erythematosus, Systemic
Similarity Score8%

Silvia Ulrich, Prof. Dr.

University Hospital Zurich, Department of Pulmonology

Related
8 trials

Shared therapeutic areas:

Lung Diseases, Interstitial
Similarity Score8%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Lupus Erythematosus, Systemic
Similarity Score8%

Mohamed AbdElmoniem

Lecturer of chest medicine faculty of medicine Mansoura university

Related
13 trials

Shared therapeutic areas:

Lung Diseases, Interstitial
Similarity Score8%

xiaofeng zeng

Peking Union Medical College Hospital

Related
10 trials

Shared therapeutic areas:

Lupus Erythematosus, Systemic
Similarity Score8%

heng Mei

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Related
7 trials

Shared therapeutic areas:

Lupus Erythematosus, Systemic
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT03024307Not ApplicableStudyChair

The Effect of OPCSP on Adherence and Clinical Outcomes Among Patients With Rheumatic Diseases

Rheumatic Diseases
Completed
NCT02741960Phase 4PrincipalInvestigator

The Effect of Metformin on Reducing Lupus Flares

Systemic Lupus Erythematosus
Completed
NCT02821689Phase 4PrincipalInvestigator

Pirfenidone in Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis

DermatopolymyositisInterstitial Lung Disease
Unknown

All 3 trials loaded